Skip to main content

Table 2 Quantitative coronary angiography evaluation at all the four endpoints

From: Polymer-free dual drug-eluting stents evaluated in a porcine model

   RVD (mm) P ER P LL (mm) P DS% P
14 day
  BMS (n = 9) 2.60 ± 0.22 0.061 1.13 ± 0.14 0.067 0.32 ± 0.11 0.655 12.43 ± 4.50 0.429
PrES (n = 10) 2.41 ± 0.31 1.25 ± 0.17 0.43 ± 0.29 19.12 ± 14.87
SES (n = 9) 2.62 ± 0.28 1.17 ± 0.08 0.34 ± 0.21 12.99 ± 7.61
DDES(n = 10) 2.36 ± 0.16 1.27 ± 0.09 0.36 ± 0.18 15.46 ± 8.07
28 day
  BMS (n = 8) 2.55 ± 0.39 0.994 1.19 ± 0.19 0.946 0.41 ± 0.39 0.409 18.26 ± 20.64 0.365
PrES (n = 8) 2.56 ± 0.31 1.16 ± 0.09 0.28 ± 0.21 10.34 ± 6.93
SES (n = 8) 2.55 ± 0.19 1.18 ± 0.12 0.18 ± 0.15 6.94 ± 5.76
DDES(n = 8) 2.52 ± 0.38 1.20 ± 0.14 0.37 ± 0.32 15.90 ± 15.14
90 day
  BMS (n = 8) 2.37 ± 0.30 0.945 1.26 ± 0.13 0.662 0.76 ± 0.36 0.767 32.71 ± 16.40 0.809
PrES (n = 8) 2.30 ± 0.22 1.29 ± 0.08 0.85 ± 0.44 37.19 ± 18.71
SES (n = 8) 2.30 ± 0.27 1.29 ± 0.10 0.83 ± 0.34 35.45 ± 15.47
DDES(n = 8) 2.34 ± 0.18 1.24 ± 0.10 0.96 ± 0.35 41.66 ± 15.79
191 day
  BMS (n = 9) 2.41 ± 0.30 0.335 1.28 ± 0.16 0.368 0.34 ± 0.31 0.079 15.76 ± 16.68 0.811
PrES (n = 9) 2.31 ± 0.29 1.24 ± 0.14 0.62 ± 0.34 27.44 ± 16.22
SES (n = 9) 2.31 ± 0.19 1.30 ± 0.10 0.41 ± 0.25 18.01 ± 11.28
DDES(n = 9) 2.52 ± 0.31 1.19 ± 0.11 0.72 ± 0.36 29.70 ± 15.11
  1. RVD reference vessel diameter, ER expansion ratio, LL lumen loss, DS% diameter stenosis %, BMS Bare-Metal Stents, PrES Probucol-Eluting Stents, SES Sirolimus-Eluting Stents, DDES Dual Drug-Eluting Stents